| Execution period | 5 years |
|---|
BSE filing, NSE: HALEOSLABS. Summary written from the filing by ALFA Finder's alert engine.
Haleos Labs Ltd: key numbers
- Share price
- ₹1,425.50
- Market cap
- ₹431.0 Cr
- Revenue (annual)
- ₹333.8 Cr
- Net profit (annual)
- ₹17.31 Cr
- P/E (TTM)
- 27.3×Sector 46.1×
- Promoter holding
- 72.11%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Haleos Labs Ltd
All →Haleos Labs Annual General Meeting
Haleos Labs Limited conducted its 20th Annual General Meeting on September 30, 2026. The meeting discussed financial statements, dividend declaration, and various director reappointments.
Haleos Labs Business Update
USFDA inspected the material subsidiary Mahi Drugs' API facility in Parawada. The inspection concluded with zero Form 483 observations.
Haleos Labs Other Announcement
Haleos Labs Ltd notified shareholders of the Annual Report and AGM notice weblink, while requesting updates to their KYC and email addresses.
Haleos Labs Annual Report
Haleos Labs Ltd has submitted its Annual Report for the financial year 2025-26, along with the Notice for its 20th Annual General Meeting.
Haleos Labs Dividend
Haleos Labs Limited recommended a final dividend of ₹15 per equity share for FY 2025-26. The record date is fixed for September 23, 2026.
Haleos Labs Annual General Meeting
Haleos Labs Limited announced postal ballot results where shareholders approved director reappointment and related party transactions. However, a resolution for managerial remuneration was rejected by shareholders.
Other management change announcements
All →Travel Food Services Management Change
Travel Food Services appointed Avinash Yogeshwar as Senior Managerial Personnel, effective 29 October 2026. It is a senior leadership change with no financial impact.
Swan Defence and Heavy Industries Management Change
Swan Defence designated three existing employees as Senior Management Personnel effective 29 October 2026, following organisational restructuring. The move reflects leadership reorganisation, not new capital or contracts.
Prima Innovation Management Change
Prima Innovation Limited reported the resignation of Non-Executive Director Dilip M. Parekh, effective 29-10-2026, citing personal reasons. The exit is a board-level change investors should note.
Strides Pharma Science Management Change
Strides Pharma's board appointed Biren Gabhawala as Non-Executive Independent Director effective November 1, 2026, for five years. He is a Chartered Accountant with extensive audit and listed-company board experience.
- Execution
- Five-year term effective November 1, 2026
Srivasavi Adhesive Tapes Management Change
Srivasavi Adhesive Tapes appointed Ms. Venugopal as Chief Financial Officer effective 29 October 2026. She holds an MBA in Finance with seven years of finance experience.
Restaurant Brands Asia Management Change
Restaurant Brands Asia appointed nine persons on October 29, 2026, including two directors, a CEO and senior management heads. Shivkumar Dega joins as a non-executive independent director.